Molecular imaging of vulnerable plaque by cardiac magnetic resonance imaging

被引:13
作者
Burgstahler, Christof
Hombach, Vinzenz
Rasche, Volker
机构
[1] Univ Tubingen, Med Klin 3, D-72076 Tubingen, Germany
[2] Univ Ulm, Med Klin 2, Ulm, Germany
关键词
plaque imaging; molecular imaging; magnetic resonance imaging; contrast agents; coronary artery disease;
D O I
10.1055/s-2007-969030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary atherosclerosis is known to be the major cause for morbidity and mortality in the industrial world. In Europe, every year similar to 600,000 persons die from coronary artery disease, a majority of them without any prior symptoms. Plaque rupture, mostly of noncalcified vulnerable plaques, is supposed to play a major role in this setting, and noninvasive techniques are mandatory to stratify the individual risk for experiencing an acute coronary event. During the last decade, magnetic resonance imaging has gained importance as a noninvasive imaging technique in cardiology. Continuous technical improvements enabled a rapidly expanding field of application, and recently noninvasive imaging of plaques has been introduced. In addition to morphological characterization, functional imaging of plaques has gained interest for a more specific risk assessment. This article summarizes pathophysiological aspects of the concept of vulnerable plaque, technical requirements for noninvasive plaque imaging, and characterization with magnetic resonance imaging.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 47 条
[1]   Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography - A segment-based comparison with intravascular ultrasound [J].
Achenbach, S ;
Moselewski, F ;
Ropers, D ;
Ferencik, M ;
Hoffmann, U ;
MacNeill, B ;
Pohle, K ;
Baum, U ;
Anders, K ;
Jang, I ;
Daniel, WG ;
Brady, TJ .
CIRCULATION, 2004, 109 (01) :14-17
[2]  
Blaimer Martin, 2004, Top Magn Reson Imaging, V15, P223, DOI 10.1097/01.rmr.0000136558.09801.dd
[3]  
Botnar RM, 2000, CIRCULATION, V102, P2582
[4]   In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent [J].
Botnar, RM ;
Buecker, A ;
Wiethoff, AJ ;
Parsons, EC ;
Katoh, M ;
Katsimaglis, G ;
Weisskoff, RM ;
Lauffer, RB ;
Graham, PB ;
Gunther, RW ;
Manning, WJ ;
Spuentrup, E .
CIRCULATION, 2004, 110 (11) :1463-1466
[5]   Initial experiences with in vivo right coronary artery human MR vessel wall imaging at 3 tesla [J].
Botnar, RM ;
Stuber, M ;
Lamerichs, R ;
Smink, J ;
Fischer, SE ;
Harvey, P ;
Manning, WJ .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2003, 5 (04) :589-594
[6]  
Botnar RM, 2001, MAGNET RESON MED, V46, P848, DOI 10.1002/mrm.1268
[7]   Coil setup optimization for 2D-SENSE whole-heart coronary imaging [J].
Buehrer, M ;
Huber, ME ;
Wiesinger, F ;
Boesiger, P ;
Kozerke, S .
MAGNETIC RESONANCE IN MEDICINE, 2006, 55 (02) :460-464
[8]   Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions - A prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging [J].
Corti, R ;
Fuster, V ;
Fayad, ZA ;
Worthley, SG ;
Helft, G ;
Chaplin, WF ;
Muntwyler, J ;
Viles-Gonzalez, JF ;
Weinberger, J ;
Smith, DA ;
Mizsei, G ;
Badimon, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :106-112
[9]  
DAVIS HH, 1978, LANCET, V1, P1185
[10]   Detection of single mammalian cells by high-resolution magnetic resonance imaging [J].
Dodd, SJ ;
Williams, M ;
Suhan, JP ;
Williams, DS ;
Koretsky, AP ;
Ho, C .
BIOPHYSICAL JOURNAL, 1999, 76 (01) :103-109